Discovery of N -(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis

Liu Yang,Xueping Hu,Yang Lu,Ruolan Xu,Yaping Xu,WanLi Ma,Md Shah Alam,Tianyu Zhang,Xin Chai,Yixuan Lei,Qing Ye,Xiaowu Dong,Yu Kang,Jinxin Che,Tingjun Hou,Dan Li

DOI: https://doi.org/10.1021/acs.jmedchem.3c01703

IF: 8.039

2024-01-19

Journal of Medicinal Chemistry

Abstract:Decaprenylphosphoryl-β-d-ribose oxidase (DprE1) is a promising target for treating tuberculosis (TB). Currently, most novel DprE1 inhibitors are discovered through high-throughput screening, while computer-aided drug design (CADD) strategies are expected to promote the discovery process. In this study, with the aid of structure-based virtual screening and computationally guided design, a series of novel scaffold N-(1-(6-oxo-1,6-dihydropyrimidine)-pyrazole) acetamide derivatives with significant...

chemistry, medicinal